FDA approves Takeda's Rozerem ramelteon

FDA granted marketing approval to Takeda (Osaka, Japan) for Rozerem ramelteon to treat insomnia characterized by difficulty with sleep onset. Takeda said Rozerem is the only non-scheduled prescription...